Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from June 2023.
insulin
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: California Enters Insulin Manufacturing: Can We Expect to See a California Effect? California Enters Insulin Manufacturing: Can We Expect to See a California Effect?
Initiatives like CalRx may have far-reaching consequences for public health and access to medicines.
-
Read more: What Democrats’ Drug Pricing Plan Means for Consumers What Democrats’ Drug Pricing Plan Means for Consumers
The new drug pricing plan creates protections against out-of-pocket costs for seniors with Medicare Part D benefits and people who take insulin.
